PARIET, ENTERIC-COATED TABLET 10MG 10 MG
RABEPRAZOLE SODIUM : 10 MG · DIN 02243796 · JANSSEN INC
Health Canada status: MARKETED
What is PARIET, ENTERIC-COATED TABLET 10MG?
PARIET, ENTERIC-COATED TABLET 10MG 10 MG contains RABEPRAZOLE SODIUM : 10 MG. It is listed in the Health Canada Drug Product Database under DIN 02243796, held by JANSSEN INC, supplied as TABLET (ENTERIC-COATED) for ORAL administration. Health Canada currently lists it as marketed, status dated 02-Apr-2002. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is PARIET, ENTERIC-COATED TABLET 10MG used for?
GERD healing/maintenance, symptomatic NERD, duodenal/gastric ulcers, pathological hypersecretory conditions (Zollinger-Ellison), and H. pylori eradication.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
What else is PARIET, ENTERIC-COATED TABLET 10MG called?
The same molecule, RABEPRAZOLE, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| APO-Rabeprazole | Latin | Australia |
| Parbezol | Latin | Australia |
| Rabeprazole Sandoz | Latin | Australia |
| RABEPRAZOLE-WGR | Latin | Australia |
| Rabeprazole Mylan | Latin | Australia |
| Rabeprazole SUN | Latin | Australia |
| Zabep | Latin | Australia |
| Pariet | Latin | South Africa |
| Rabeprazole Viatris | Latin | Australia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 02243796 |
|---|---|
| Brand name | PARIET, ENTERIC-COATED TABLET 10MG |
| Generic / active ingredient | RABEPRAZOLE SODIUM : 10 MG |
| Manufacturer | JANSSEN INC |
| Strength | 10 MG |
| Dosage form | TABLET (ENTERIC-COATED) |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | A02BC04 RABEPRAZOLE |
| AHFS class | 56:28.36 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 02-Apr-2002 |
| Original market date | 2002-04-02 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02243796 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2243796 |
| Brand name | PARIET, ENTERIC-COATED TABLET 10MG |
| Active ingredient / INN | RABEPRAZOLE SODIUM : 10 MG |
| ATC code | A02BC04 |
| ATC anatomical main group | A — Alimentary tract and metabolism |
| ATC therapeutic subgroup | A02 |
| AHFS class | 56:28.36 |
| Health Canada schedule | Prescription |
| Biosimilar biologic | No |
| Market authorization holder | JANSSEN INC |
How is it administered?
Adults: 10-20 mg QD for GERD/Ulcers; 60 mg QD starting dose for hypersecretory conditions. H. pylori: 20 mg BID with amoxicillin/clarithromycin for 7 days. Swallow whole.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Not explicitly detailed in provided text snippet (Section 11 listed in TOC but content missing), though typically 15-30°C for this class.
How is it supplied?
10 mg and 20 mg tablets are available in HDPE bottles of 100.
Which pack is which?
| Strength on the label | 10 MG |
|---|---|
| Dosage form | TABLET (ENTERIC-COATED) |
| Route | ORAL |
| Packaging as described in the monograph | 10 mg and 20 mg tablets are available in HDPE bottles of 100. |
| Storage | Not explicitly detailed in provided text snippet (Section 11 listed in TOC but content missing), though typically 15-30°C for this class. |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation, because this listing covers more than one of them.
Contraindications
Hypersensitivity to rabeprazole or substituted benzimidazoles; co-administration with rilpivirine; contraindications for amoxicillin/clarithromycin when used in H. pylori regimens.
Warnings and precautions
Exclude gastric malignancy; risk of C. difficile-associated diarrhea; hypomagnesemia; bone fracture risk (long-term/high-dose); fundic gland polyps; SCLE; Vitamin B12 deficiency.
What can be used instead?
Other Canadian products sharing ATC code A02BC04 RABEPRAZOLE. 8 of 38 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| PARIET, ENTERIC-COATED TABLET 20MG | 20 MG | TABLET (ENTERIC-COATED) | JANSSEN INC | MARKETED | DIN 02243797 |
| RABEPRAZOLE | 10 MG | TABLET (ENTERIC-COATED) | SIVEM PHARMACEUTICALS ULC | MARKETED | DIN 02385449 |
| RABEPRAZOLE | 20 MG | TABLET (ENTERIC-COATED) | SIVEM PHARMACEUTICALS ULC | MARKETED | DIN 02385457 |
| RABEPRAZOLE EC | 10 MG | TABLET (ENTERIC-COATED) | SANIS HEALTH INC | MARKETED | DIN 02356511 |
| RABEPRAZOLE EC | 20 MG | TABLET (ENTERIC-COATED) | SANIS HEALTH INC | MARKETED | DIN 02356538 |
| SANDOZ RABEPRAZOLE | 10 MG | TABLET (ENTERIC-COATED) | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02314177 |
| SANDOZ RABEPRAZOLE | 20 MG | TABLET (ENTERIC-COATED) | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02314185 |
| ABBOTT-RABEPRAZOLE | 10 MG | TABLET (DELAYED-RELEASE) | BGP PHARMA ULC | CANCELLED POST MARKET | DIN 02422638 |
| ABBOTT-RABEPRAZOLE | 20 MG | TABLET (DELAYED-RELEASE) | BGP PHARMA ULC | CANCELLED POST MARKET | DIN 02422646 |
| AG-RABEPRAZOLE | 10 MG | TABLET (DELAYED-RELEASE) | ANGITA PHARMA INC. | APPROVED | DIN 02484161 |
Who else supplies RABEPRAZOLE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. RABEPRAZOLE appears in 466 registered pack listings across 10 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How much does RABEPRAZOLE cost around the world?
RABEPRAZOLE is listed on 4 national price registers Nexara tracks, across 69 pack listings published on 4 different price bases. What each country publishes is set out below.
| Market | What that country publishes | Brands listed | Pack listings | As of |
|---|---|---|---|---|
| Australia | ex-manufacturer | 8 | 59 | 08 Sep 2026 |
| Greece | producer price (ex-factory) | 6 | 6 | 03 Sep 2026 |
| United Kingdom | hospital | 2 | 2 | 31 Aug 2026 |
| South Africa | single exit price | 1 | 2 | 01 Sep 2026 |
Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.